Entry |
|
Name |
Metandienone (INN); Methandrostenolone; Dianabol (TN) |
Formula |
C20H28O2
|
Exact mass |
300.2089
|
Mol weight |
300.43
|
Structure |
|
Simcomp |
|
Class |
Hormonal agent
DG01590 Androgen receptor agonist
DG01605 Anabolic steroid
|
Remark |
|
Efficacy |
Anabolic, Androgen receptor agonist |
Comment |
Androstan derivative
|
Target |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A14 ANABOLIC AGENTS FOR SYSTEMIC USE
A14A ANABOLIC STEROIDS
A14AA Androstan derivatives
A14AA03 Metandienone
D00389 Metandienone (INN)
D DERMATOLOGICALS
D11 OTHER DERMATOLOGICAL PREPARATIONS
D11A OTHER DERMATOLOGICAL PREPARATIONS
D11AE Androgens for topical use
D11AE01 Metandienone
D00389 Metandienone (INN)
Drug groups [BR:br08330]
Hormonal agent
DG01590 Androgen receptor agonist
DG01605 Anabolic steroid
D00389 Metandienone
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C4 (AR)
D00389 Metandienone (INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 22
1 C1y C 24.7158 -17.3365
2 C1y C 23.5376 -16.6424
3 C1y C 25.8937 -16.6600
4 C1x C 24.7158 -18.7012
5 C1z C 22.3537 -17.3249
6 C1x C 23.5493 -15.2836
7 C1z C 25.9113 -15.3011
8 C1x C 28.2558 -16.6891
9 C1x C 23.5259 -19.3778
10 C2y C 22.3479 -18.6896
11 C2x C 21.1698 -16.6367
12 C1x C 24.7391 -14.6071
13 C1z C 27.1010 -14.6362
14 C1x C 28.2732 -15.3303
15 C2x C 21.1698 -19.3718
16 C2x C 19.9801 -17.3249
17 C1a C 28.4249 -13.8022
18 O1a O 27.1069 -12.9099
19 C5x C 19.9801 -18.6896
20 O5x O 18.8020 -19.3718
21 C1a C 22.3537 -15.9249
22 C1a C 25.9113 -13.9011
BOND 25
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 1
9 5 10 1
10 5 11 1
11 6 12 1
12 7 13 1
13 8 14 1
14 10 15 2
15 11 16 2
16 13 17 1 #Down
17 13 18 1 #Up
18 15 19 1
19 19 20 2
20 7 12 1
21 9 10 1
22 13 14 1
23 16 19 1
24 5 21 1 #Up
25 7 22 1 #Up
|